Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

Author(s):
Orsi, F.A.; Biedermann, J.S.; Kruip, M.J.H.A.; Meer, F.J. van der; Rosendaal, F.R.; Vlieg, A.V.; Bos, M.H.A.; Leebeek, F.W.G.; Cannegieter, S.C. (0000-0003-4707-2303); Lijfering, W.M.
Published
2019
Publication type
Article / Letter to editor
hydroxymethylglutaryl-CoA reductase inhibitorsrandomized clinical trialthrombin generationthrombophiliavenous thrombosis
Date issued
2019-02-28
Language
English
Is part of
Journal of Thrombosis and Haemostasis (2019), Vol. 17, no. 2, p. 319-328
hdl
1887/119874
doi
10.1111/jth.14364